Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.

Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.

Item
http://www.wikidata.org/entity/Q34790458
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesCorrection of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophyAntisense-mediated exon skipping: a versatile tool with therapeutic and research applicationsDynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides.Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal musclesBifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.The potential of antisense as a CNS therapeutic.Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.A prospective study in the rational design of efficient antisense oligonucleotides for exon skipping in the DMD gene.Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.Telomerase - strategies to exploit an important chemotherapeutic target.A cationic morpholino antisense oligomer conjugate: synthesis, cellular uptake and inhibition of Gli1 in the hedgehog signalling pathway
P2860

Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.

Item
http://www.wikidata.org/entity/Q34790458
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
type
label
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
prefLabel
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Modification of alternative sp ...... for cancer and other diseases.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921